Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
The EMBO Journal|October 17, 2008
Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1Steffi Herold, Andreas Hock, Barbara Herkert, et al.Personalized Medicine|May 20, 2018
Performance characteristics of the MammaPrint® breast cancer diagnostic gene signatureLeonie Jm Delahaye, Diederik Wehkamp, Arno N Floore, et al.Nature Reviews. Clinical Oncology|April 17, 2021
Precision oncology in metastatic colorectal cancer - from biology to medicineFederica Di Nicolantonio, Pietro Paolo Vitiello, Silvia Marsoni, et al.Nature Cell Biology|June 15, 2007
The ubiquitin-specific protease USP28 is required for MYC stabilityNikita Popov, Michael Wanzel, Mandy Madiredjo, et al.Future Oncology (London, England)|March 4, 2020
Vorinostat in patients with resistant BRAF mutated advanced melanoma: a proof of concept studySanne Huijberts, Liqin Wang, Rodrigo Leite de Oliveira, et al.Bioinformatics (Oxford, England)|July 17, 2012
A regression model for estimating DNA copy number applied to capture sequencing dataGuillem J Rigaill, Sidney Cadot, Roelof J C Kluin, et al.Cell|June 18, 2005
A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicityIngrid G M Kolfschoten, Bart van Leeuwen, Katrien Berns, et al.NPJ Breast Cancer|April 25, 2019
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancersFloris H Groenendijk, Tina Treece, Erin Yoder, et al.Cell Reports|September 10, 2014
RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cellsSimona Lamba, Mariangela Russo, Chong Sun, et al.Gut|July 17, 2012
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment predictionSun Tian, Iris Simon, Victor Moreno, et al.Pageof 8